We aspire to keep the wonderful world visible for all

Welcome to Revenio's investor website

Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

In 2021, the Group's net sales totaled EUR 78.8 million, with its operating profit standing at 28.1%. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Latest report

January-June Half-Year Financial Report 2022

null

Upcoming event

Audiocast for Half-year report, August 4 at 3 p.m. EEST

Press releases

IR contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi

Share price {{stockPriceLatestDate}}: {{stockPrice}} {{currency}}

Revenio is listed on Nasdaq Helsinki

Analyses

Revenio is followed by Carnegie, Inderes, OP and SEB